EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan

Tadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, Mitsuhiro Takeno iD

Journal of Gastroenterology · 2025

DOI: 10.1007/s00535-024-02191-y ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Tadakazu Hisamatsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Behcet Syndrome, Gastrointestinal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ferring Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Behçet’s disease (BD) is an autoinflammatory disease that can affect multiple organs, including the gastrointestinal tract. Conventional management comprises anti-inflammatory drugs such as glucocorticoids (GCs) and/or immunomodulators that alleviate symptoms. The introduction of biological agents that target tumor necrosis factor α (TNF-α) has improved disease management. The goal of this work was to analyze the current prevalence and incidence of total BD and gastrointestinal Behçet’s disease (GIBD) in Japan, and examine treatment trends, especially regarding the use of TNF-α inhibitors (TNFαi).

Methods

We performed a retrospective descriptive observational study in which BD and GIBD demographic trends, medical treatment patterns, and reported adverse events (AEs) were assessed among patients with data recorded between 2017 and 2021 in the Japan Medical Data Center Claims Database (now JMDC Inc.).

Results

Prevalence of BD and GIBD in Japan during the observation period increased at an annual rate of + 3% and + 4%, respectively, while incidence decreased by − 5% and − 2%, with a more prominent decline in confirmed GIBD cases (− 15%). Although GCs were the most common initial treatment administered, use of TNFαi for BD and GIBD management increased by + 5.6% and + 8.1%, respectively. Severe AEs (mainly pneumonia and GI-associated AEs) were reported in 40% of patients receiving TNFαi; however, a high retention rate (of up to 80%) was observed 3 years after treatment initiation.

Conclusion

The use of TNFαi for GIBD treatment has increased in Japan in recent years. Additional research is necessary to further evaluate TNFαi effectiveness in GIBD and other BD subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromeGastrointestinal DiseasesHumansJapanRetrospective StudiesIncidencePrevalenceMaleFemaleAdultTumor Necrosis Factor-alphaMiddle AgedGlucocorticoidsAgedYoung Adult

Stichwörter der Autor:innen

Behçet’s diseaseGastrointestinal Behçet’s diseaseJapanTNFαiTreatment trends

Substanzen

Tumor Necrosis Factor-alphaGlucocorticoids

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Division of Gastroenterology and Hepatology, Third Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, Japan.
  • Clinical and Translational Sciences, Ferring Pharmaceuticals, 2770, Kastrup, Denmark.
  • Department of Allergy and Rheumatology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Kanagawa, Japan. m-takeno@nms.ac.jp.

ORCID-Profile: Mitsuhiro Takeno

Förderung

  • Ferring Pharmaceuticals

Zitieren

APA

Hisamatsu, T., Naganuma, M., Pinton, P., & Takeno, M. (2025). Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02191-y

Vancouver

Hisamatsu T, Naganuma M, Pinton P, Takeno M. Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan. Journal of Gastroenterology. 2025. doi:10.1007/s00535-024-02191-y

BibTeX
@article{Hisamatsu2025,
  author = {Hisamatsu, Tadakazu and Naganuma, Makoto and Pinton, Philippe and Takeno, Mitsuhiro},
  title = {Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan},
  journal = {Journal of Gastroenterology},
  year = {2025},
  doi = {10.1007/s00535-024-02191-y}
}
Kostenlos starten →